Steven J. Mento founded Conatus Pharmaceuticals, Inc. Presently, he is President, Chief Executive Officer & Director at this company. Dr. Mento is also on the board of BIOCOM, BIO Emerging Co. and Donald P. Shiley Bioscience Center and Director & Member-Health Section at Biotechnology Innovation Organization.
Dr. Mento previously held the position of Vice President-Research & Development of Viagene, Inc., Director-Viral Vaccine Research & Development at Lederle Praxis Biological, Inc., President, Chief Executive Officer & Director at Idun Pharmaceuticals, Inc., Vice President-Research & Development at Chiron Viagene, Inc., Vice President-Research & Development at Chiron Corp. and Assistant Research Professor at Icah School of Medicine at Mount Sinai.
He received a doctorate, a graduate degree and an undergraduate degree from Rutgers State University of New Jersey.